Agree that theyvare doing good research regarding use of cannabidiol in animals.
but as a shareholder I am worried that these are probably not patented formulations and anyone could theoretically copy and sell..
Cannpal may be credited with the research findings but will that lead to commercial benefit?
- Forums
- ASX - By Stock
- CP1
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-3
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CP1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online